Page last updated: 2024-08-23

mifepristone and Adrenal Gland Hyperfunction

mifepristone has been researched along with Adrenal Gland Hyperfunction in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afonnikova, ED; Kuz Minova, OI; Pal Chikova, NA; Selyatitskaya, VG	1
de Kloet, ER; De Nicola, AF; Louwe, MC; Oitzl, MS; Rekers, NV; Revsin, Y; Saravia, FE	1
Young, AH	1
Lamberts, SW	1

Reviews

2 review(s) available for mifepristone and Adrenal Gland Hyperfunction

Article	Year
Antiglucocoticoid treatments for depression. The Australian and New Zealand journal of psychiatry, 2006, Volume: 40, Issue:5 Topics: Adrenocortical Hyperfunction; Dehydroepiandrosterone; Depressive Disorder, Major; Enzyme Inhibitors; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Metyrapone; Mifepristone; Pituitary-Adrenal System	2006
[Oncological and endocrine administration of the antiprogestagen RU 486]. Nederlands tijdschrift voor geneeskunde, 1990, Dec-29, Volume: 134, Issue:52 Topics: Adrenocortical Hyperfunction; Breast Neoplasms; Female; Humans; Meningeal Neoplasms; Meningioma; Mifepristone	1990

Other Studies

2 other study(ies) available for mifepristone and Adrenal Gland Hyperfunction

Article	Year
[Hypercorticism during streptozotocin diabetes and mifepristone administration: the role of cyclic adenosine monophosphate]. Biomeditsinskaia khimiia, 2019, Volume: 65, Issue:4 Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Corticosterone; Cyclic AMP; Diabetes Mellitus, Experimental; Mifepristone; Rats	2019
Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3 Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Cell Proliferation; Cognition; Corticosterone; Diabetes Mellitus, Experimental; Exploratory Behavior; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Ki-67 Antigen; Male; Memory; Mice; Mice, Inbred C57BL; Mifepristone; Nerve Tissue Proteins; Proto-Oncogene Proteins c-jun; Receptors, Glucocorticoid	2009

Article

Year

[Hypercorticism during streptozotocin diabetes and mifepristone administration: the role of cyclic adenosine monophosphate].

Biomeditsinskaia khimiia, 2019, Volume: 65, Issue:4

Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Corticosterone; Cyclic AMP; Diabetes Mellitus, Experimental; Mifepristone; Rats

2019

Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3

Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Cell Proliferation; Cognition; Corticosterone; Diabetes Mellitus, Experimental; Exploratory Behavior; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Ki-67 Antigen; Male; Memory; Mice; Mice, Inbred C57BL; Mifepristone; Nerve Tissue Proteins; Proto-Oncogene Proteins c-jun; Receptors, Glucocorticoid

2009